|
|
|
In an article published in Gene Therapy (Vol. 13, pp. 1133–1142), a group of scientists, led by Dr. R. Laguens, conclude that plasmid-mediated VEGF gene transfer reduces myocardial infarct size by a combination of effects including neovascular proliferation, modification of fibrosis and cardiomyocyte regeneration.
Correspondence:
Dr. R. Laguens, Department of Pathology, Favaloro University, Solís 453 (1078) Buenos Aires, Argentina.
E-mail: rlaguens@ffavaloro.orgAbstract available online. (C) Gene Therapy. Posted by: Tressie Dalaya
Message posted by: Trevor M. D'Souza
|
|
Variants Associated with Pediatric Allergic Disorder
Mutations in PHF6 Found in T-Cell Leukemia
Genetic Risk Variant for Urinary Bladder Cancer
Antibody Has Therapeutic Effect on Mice with ALS
Regulating P53 Activity in Cancer Cells
Anti-RNA Therapy Counters Breast Cancer Spread
Mitochondrial DNA Diversity
The Power of RNA Sequencing
‘Pro-Ageing' Therapy for Cancer?
Niche Genetics Influence Leukaemia
Molecular Biology: Clinical Promise for RNA Interference
Chemoprevention Cocktail for Colon Cancer
more news ...
|